Trial
NCT02837042
Trial of Pembrolizumab for Advanced Penile Squamous Cell Carcinoma
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Alabama at Birmingham
Collaborators
Merck Sharp & Dohme LLC
Condition
Penile Squamous Cell Carcinoma
Intervention
Pembrolizumab
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-06-21